In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...

Teva Pharmaceutical Industries TEVA reported fourth-quarter 2024 adjusted earnings of 71 cents per share, which beat the ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Discover top quality stocks for long-term investment to guard against volatility and benefit during market strength.

This was the stock's second consecutive day of gains.

The company reports its latest results Feb. 4, and there are several things investors should assess. Corporate America just kicked off a new quarterly earnings season. Over the next few weeks, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Takeda Pharmaceutical Company Limited ( NYSE: TAK) Q3 2025 Results Conference Call January 30, 2025 5:30 AM ET Christopher O’Reilly - Head, Investor Relations Christophe Weber - President and Chief ...

BMO Capital Markets updated its financial outlook on Ameren Corp . (NYSE: NYSE:AEE), increasing the price target to $100 from $94, while maintaining an Outperform rating. The adjustment comes ahead of ...